fda warning letters glp-1 october 2025 news FDA issues 30 warning letters to online GLP-1 compounders

FDA Issues 30 Warning Letters to Telehealth Firms Over Misleading Compounded GLP-1 Marketing

23.62

★★★★☆4.8 (126)

FDA Issues 30 Warning Letters to Telehealth Companies Over GLP-1 Claims | FDA posted on the topic

27.73

★★★★★4.9 (98)

Telehealth booms as demand for GLP-1s surges and questions mount about safety, oversight

26.29

★★★★★5.0 (157)

The Food and Drug Administration (FDA) on Tuesday sent 30 telehealth companies warning letters about their “illegal” sales of compounded GLP-1s, building off increasing pressure to tamp down on the sale of

25.38

★★★★★4.7 (84)

Compound versions of GLP-1 drugs for weight loss halted by FDA

28.54

★★★★★4.9 (203)

The U.S. Food and Drug Administration (FDA) has issued a warning to Novo Nordisk over its alleged failure to report adverse side effects, including death, in patients who took its GLP-1 medications,

27.49

★★★★★5.0 (176)

FDA Issues Warning Letters to 30 Telehealth Companies Over Misleading Compounded GLP-1 RA Marketing

29.50

★★★★★4.8 (132)